GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Total Long-Term Assets

J.Molner AS (OTSE:MOLNR) Total Long-Term Assets : €2.65 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. J.Molner AS's Total Long-Term Assets for the quarter that ended in Dec. 2023 was €2.65 Mil.


J.Molner AS Total Long-Term Assets Historical Data

The historical data trend for J.Molner AS's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Total Long-Term Assets Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Total Long-Term Assets
0.11 0.93 2.65

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Total Long-Term Assets 0.11 0.35 0.93 1.41 2.65

J.Molner AS Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.


J.Molner AS Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines